| 前收市價 | 125.23 |
| 開市 | 125.65 |
| 買盤 | 0.00 x 800 |
| 賣出價 | 0.00 x 900 |
| 今日波幅 | 124.89 - 126.12 |
| 52 週波幅 | 99.14 - 133.10 |
| 成交量 | |
| 平均成交量 | 8,314,271 |
| 市值 | 318.605B |
| Beta 值 (5 年，每月) | 0.40 |
| 市盈率 (最近 12 個月) | 898.43 |
| 每股盈利 (最近 12 個月) | 0.14 |
| 業績公佈日 | 2024年4月25日 |
| 遠期股息及收益率 | 3.08 (2.45%) |
| 除息日 | 2024年3月14日 |
| 1 年預測目標價 | 137.02 |
Insider Monkey13 Best Low Volatility Stocks to Buy According to Hedge Funds
In this article, we discuss the 13 best low volatility stocks to buy according to hedge funds. To skip the detailed analysis of the current market conditions, go directly to the 5 Best Low Volatility Stocks to Buy According to Hedge Funds. The S&P 500 had a remarkable year in 2023 and the first quarter […]
Insider Monkey10 Best Low Volatility ETFs To Buy
In this article, we discuss 10 best low volatility ETFs to buy. If you want to skip our discussion on low volatility investments, head over to 5 Best Low Volatility ETFs To Buy. What is Low Volatility Investing? Low volatility investing refers to an investment strategy where a stock portfolio is less volatile in terms […]
InvestorPlace7 A-Rated Aggressive Biotech Stocks to Bet On in 2024
The best biotech stocks to buy are in companies that put a lot of resources into research and development, often with nothing to show for it for years. Regulatory hurdles make finding biotech stocks to buy challenging if you don’t have the patience to wait it out. But when biotech companies win approval to sell and marketing a drug, the potential for profits can be off the charts. That’s why it’s a good idea to at least consider biotech, and whether they have a spot in your portfolio.InvestorPla
